CD8A and myelodysplastic syndrome: Expression of TIM-3 was also detected on CD8+ T cells in myelodysplastic syndrome (MDS), demonstrating how this ligand is not exclusively involved in the exhaustion of immune cells committed to the recognition and elimination of solid tumors.